Axa’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Axa’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-195,253	Closed	-$5.16M	–	1534
2014 Q4	$5.16M	Sell	195,253 -365,465	-65%	-$10.7M	0.02%	549
2014 Q3	$16.9M	Sell	560,718 -1,929	-0.3%	-$59.7K	0.07%	284
2014 Q2	$17.7M	Buy	562,647 +8,640	+2%	+$274K	0.07%	290
2014 Q1	$17.9M	Sell	554,007 -30,526	-5%	-$1.07M	0.08%	274
2013 Q4	$21.3M	Sell	584,533 -24,441	-4%	-$950K	0.1%	239
2013 Q3	$23.7M	Buy	608,974 +391,769	+180%	+$15.8M	0.12%	201
2013 Q2	$8.13M	Buy	+217,205	New	+$8.58M	0.04%	386

Other funds holding MR

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

GAM

Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Axa's MR Position: Q1 2015 in Review

Axa sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2015, closing a stake of 195,253 shares — an estimated $5.16M sold.

Axa first reported a position in MR in Q2 2013 and held it in 7 quarters. The position peaked at $23.7M in Q3 2013. 124 funds tracked by Wall St. Rank hold MR as of Q1 2015.

Axa reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2015 after selling out during the quarter.
Axa sold 195,253 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2015, an estimated $5.16M.
Axa first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 7 quarters.
Axa's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $23.7M in Q3 2013.
124 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2015.

Based on Axa's 13F filing for Q1 2015, filed 13 May 2015.